Andreas Karachristos

Universiyersity of South Florida

Appearances

SURVIVAL ANALYSIS OF PATEINTS WITH T2 HEPATOCELLULAR CARCINOMA AFTER LIVER TRANSPLNATATION VERSUS RESECTION USING THE UNOS AND NCDM DATABASES.
Date
May 9, 2023
BACKGROUND: The majority of HCC patients within Milan criteria, compete with cirrhosis patients with high MELD for liver transplantation based on an exceptional score which is the calculated MELD at registration, 28 after six months of waiting, 31 after 1 year and thereafter capped at 34 after one…
Presenter
Amar Mukerji
Speakers
Timothy Nywening
Andreas Karachristos
Universiyersity of South Florida
COLORECTAL CANCER PRIMES LIVER RECRUITMENT OF CCR2+ TUMOR ASSOCIATED MACROPHAGES TO ESTABLISH A PRE-METASTATIC NICHE
Date
May 8, 2023
Pancreatic Adenocarcinoma (PDAC) is highly lethal due to overwhelming metastatic burden. The mechanisms underpinning metastasis in PDAC are lacking. The TMEM doorway is the sole portal of intravasation in breast cancer (BC)…
Speaker
Timothy Nywening
Presenter
Andreas Karachristos
Universiyersity of South Florida
SSAT Video Session: Hepatobiliary and Pancreatic Diseases II
Date
May 6, 2023
SOCIETY: SSAT
Moderators
Monica Dua
Stanford University
Andreas Karachristos
Universiyersity of South Florida
Gregor Stavrou
Klinikum Saarbrucken gGmbH